Boiron

Boiron (Euronext: BOI) is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it employed a workforce of 2,779 and had a turnover of € 313 million. It is currently a member of the CAC Small 90 stock index.

In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.

Products of Boiron include mono- (Hahnemanian) preparations and poly- (which Boiron called "Proprietary drugs").

Several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive.

Blogzero backlash

Samuele Riva, an Italian blogger, wrote an entry about the implausibility of homeopathy including images of Boiron's top-selling product. The company sent a letter to the Internet provider for the blog, but the result was a backlash in favor of freedom of speech.